Anebulo Pharmaceuticals, Inc. (ANEB): Total Assets
$12.15M
As of 2025-06-30
$9.42M
As of 2025-12-31
-8.0%
3-year compound annual growth
+32.0%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | $12.15M | +198.2% | 2025-09-29, Balance as of period end |
| 2024-06-30 | $4.07M | -65.1% | 2025-09-29, Balance as of period end |
| 2023-06-30 | $11.67M | -25.1% | 2024-09-25, Balance as of period end |
| 2022-06-30 | $15.58M | -28.1% | 2023-09-22, Balance as of period end |
| 2021-06-30 | $21.65M | +615.0% | 2022-09-09, Balance as of period end |
| 2020-06-30 | $3.03M | n/a | 2021-09-22, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | $12.15M | +198.2% |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | $12.16M | +493.6% |
| Imunon, Inc. (IMNN) | 2025-12-31 | $12.29M | +26.5% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $12.00M | +165.1% |
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | $12.73M | n/m |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $11.58M | +74.9% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $11.58M | n/m |
| Propanc Biopharma, Inc. (PPCB) | 2026-06-30 | $12.78M | -34.9% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $12.87M | +43.1% |
Compare ANEB, TTRX, IMNN, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗